FREE MEMBERSHIP Includes » ABL Advisor eNews + iData Blasts | JOIN NOW ABLAdvisor Gray ABLAdvisor Blue
Skip Navigation LinksHome / Press Releases / Read Press Release


MonoSol Rx Closes $50MM Credit Facility With Perceptive Advisors

August 19, 2016, 07:27 AM
Filed Under: Pharmaceuticals

MonoSol Rx, a specialty pharmaceutical company leveraging its PharmFilm drug delivery technology to improve patient outcomes and to address unmet needs, announced the closing of a $50 million credit facility with Perceptive Advisors. The proceeds from the credit facility will be used to repay an existing debt facility with White Oak Global Advisors and to advance the Company’s clinical-stage drug candidates, including exciting prospects in its CNS portfolio.

“Securing a sizeable credit facility with a leading global life sciences fund such as Perceptive Advisors is a significant accomplishment for MonoSol Rx and provides an important validation for the Company and our PharmFilm® technology platform,” said Keith Kendall, CEO of MonoSol Rx. “This credit facility will allow us to repay our outstanding debt to White Oak and provide us with important working capital as we continue to advance our broad pipeline of PharmFilm® based clinical-stage assets. We are grateful to White Oak for their financial support over the last eight years, and look forward to having Perceptive Advisors as our new financing partner.”

“MonoSol Rx represents a unique opportunity in the specialty pharmaceutical space. With their proprietary PharmFilm® technology, they have built a robust portfolio of commercial products and promising clinical candidates,” added Sam Chawla, Portfolio Manager at Perceptive Advisors. “We are pleased to support MonoSol Rx with its financing needs and look forward to participating in the Company’s future success.”

Perceptive Advisors is focused on supporting the progress of the life sciences industry by identifying opportunities and directing financial resources to the most promising technologies in healthcare.

MonoSol Rx is a specialty pharmaceutical company leveraging its proprietary PharmFilm® drug delivery technology to develop products that improve patient outcomes and address unmet needs.

Comments From Our Members

You must be an ABL Advisor member to post comments. Login or Join Now.